[Futraful and UFT, their metabolic characteristics].

S Suga(Higashi Nagoya National Hospital), Yoshihito Yokoyama(Hirosaki University), Yoshiko Usami(University of Massachusetts Chan Medical School), Yûji Takahashi(National Center of Neurology and Psychiatry), N Suzui, Sahoko Ichihara(Jichi Medical University), Hakutaka Hashizume(Higashi Nagoya National Hospital), Ina K, Yoh Horiuchi(Japanese Red Cross Nagoya Daiichi Hospital), Keiji Yasue(Higashi Nagoya National Hospital)
PubMed
July 1, 1987
Cited by 0

Related Papers

Environmental arsenic exposure and its contribution to human diseases, toxicity mechanism and management
|Environmental Pollution|2021|582
SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
|Nature|2015|466
Structural Basis for Budding by the ESCRT-III Factor CHMP3
|Developmental Cell|2006|254
Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface
|Biochemical Journal|1993|213
Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding
|Proceedings of the National Academy of Sciences|2006|182